HEALTH● LOWJun 26 · Jun 26, 2026, 6:40 PM
China Approves CARsgen’s CAR-T Treatment for Stomach Cancer
Human Progress
“China’s drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients’ immune cells to recognise and kill cancer cells. The injection, also known as satri-cel, is globally the first approved CAR-T cell therapy for solid tumors, CARsgen CEO Li Zonghai told […] The post China Approves CARsgen’s CAR-T Treatment for Stomach Cancer appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH14m agoLagos orders registration of pregnant women turned away at hospitalVanguard NigeriaHEALTH46m agoLaura Berbel, rheumatologist: 'Muscle mass begins to be lost at a rate of 8% every ten years from the age of 40'ClarínHEALTH1h agoAndhra University students attend Heartfulness session on stress management and well-beingThe HinduHEALTH1h agoDRC Ebola outbreak passes 9,000 cases, including more than 4,000 deathsAfricanews [en]